Article Listing - GlaxoSmithKline buys full control of Cellzome

BIOGEN'S DAVID CUOCO

4 May 1992

Biogen has appointed David Cuoco as vice president and legal counsel for the company. Mr Cuoco was formerly senior vice...

APPOINTMENTS AT BAYER

4 May 1992

Mannfred Schneider has been named as president of Bayer AG of Germany, in succession to Hermann Strenger. Dr Schneid-er is...

DERMALIFE ACQUIRES IDIM

4 May 1992

The Italian company Dermalife, which specializes in skin care products, has announced that it has acquired total control of the...

PFIZER RESEARCH SPENDING IN 1992

4 May 1992

US pharmaceutical manufacturer Pfizer said that it intends to spend $866 million on research and development in the current year,...

STOCK MARKET COMMENTARY: NEW YORK

4 May 1992

NEW YORK: ended the re-porting week with a skid, albeit up on the previous week's close, as investors moved their...

BEHRINGWERKE SALES JUMP 15.8%

4 May 1992

The German biological and diagnostic products-manufacturing subsidiary of Hoechst, Behringwerke, saw worldwide sales increase by 15.8% to 1.93 billion Deutschemarks...

DAINIPPON STARTS US ZONISAMIDE TRIALS

4 May 1992

Dainippon Pharmaceutical is shortly to start clinical development of its anti-epileptic zonisamide in the USA, according to Pharma Japan. The...

EMIP STUDY BACKS EARLY USE OF EMINASE

4 May 1992

Reporting from the annual meeting of the American College of Cardiology in Dallas, USA, the chief coordinator of the European...

COMPANIES DO MORE LICENSING DEALS

4 May 1992

There has been an increase in out-licensing of late-stage development drugs or mature drug product lines from research-intensive established drug...

US FDA APPROVABLE LETTER TO PFIZER

4 May 1992

The US Food and Drug Administr-ation has issued an "approvable" letter for Norvasc (amlodipine), a calcium channel blocker for the...

Showing 94311-94320 of 95576 articles